800
Participants
Start Date
June 30, 2008
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
ambrisentan
ambrisentan
GSK Investigational Site, Brussels
GSK Investigational Site, Darlinghurst
GSK Investigational Site, Leuven
GSK Investigational Site, Melbourne
GSK Investigational Site, Chermside
GSK Investigational Site, Bergen
GSK Investigational Site, Orbassano (TO)
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Marseille
GSK Investigational Site, Marseille
GSK Investigational Site, Córdoba
GSK Investigational Site, Caen
GSK Investigational Site, Treuenbrietzen
GSK Investigational Site, Greifswald
GSK Investigational Site, Hamburg
GSK Investigational Site, Großhansdorf
GSK Investigational Site, Lübeck
GSK Investigational Site, Besançon
GSK Investigational Site, Pavia
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Málaga
GSK Investigational Site, Brest
GSK Investigational Site, Hanover
GSK Investigational Site, Toulouse
GSK Investigational Site, Ourense
GSK Investigational Site, Bordeaux
GSK Investigational Site, Pessac
GSK Investigational Site, Montpellier
GSK Investigational Site, Rennes
GSK Investigational Site, Giessen
GSK Investigational Site, Pontevedra
GSK Investigational Site, Tours
GSK Investigational Site, Grenoble
GSK Investigational Site, Bologna
GSK Investigational Site, Seville
GSK Investigational Site, Solingen
GSK Investigational Site, Nantes
GSK Investigational Site, Toledo
GSK Investigational Site, Essen
GSK Investigational Site, Valencia
GSK Investigational Site, Moers
GSK Investigational Site, Florence
GSK Investigational Site, Cologne
GSK Investigational Site, Reims
GSK Investigational Site, Aachen
GSK Investigational Site, Vandœuvre-lès-Nancy
GSK Investigational Site, Mainz
GSK Investigational Site, Pisa
GSK Investigational Site, Thessaloniki
GSK Investigational Site, Lille
GSK Investigational Site, Strasbourg
GSK Investigational Site, Alexandroupoli
GSK Investigational Site, Mannheim
GSK Investigational Site, Heidelberg
GSK Investigational Site, Heidelberg
GSK Investigational Site, Bron
GSK Investigational Site, Gerlingen
GSK Investigational Site, Löwenstein
GSK Investigational Site, Rouen
GSK Investigational Site, Donaueschingen
GSK Investigational Site, Freiburg im Breisgau
GSK Investigational Site, Napoli
GSK Investigational Site, Munich
GSK Investigational Site, Poitiers
GSK Investigational Site, Ulm
GSK Investigational Site, Palermo
GSK Investigational Site, Clamart
GSK Investigational Site, Regensburg
GSK Investigational Site, Catania
GSK Investigational Site, Edmonton
GSK Investigational Site, Vancouver
GSK Investigational Site, Winnipeg
GSK Investigational Site, Halifax
GSK Investigational Site, London
GSK Investigational Site, Toronto
GSK Investigational Site, Montreal
GSK Investigational Site, Prague
GSK Investigational Site, Prague
GSK Investigational Site, Aarhus N
GSK Investigational Site, Cottbus
GSK Investigational Site, Dresden
GSK Investigational Site, Leipzig
GSK Investigational Site, Athens
GSK Investigational Site, Thessaloniki
GSK Investigational Site, Voula / Athens
GSK Investigational Site, Rome
GSK Investigational Site, Amsterdam
GSK Investigational Site, Amsterdam
GSK Investigational Site, Groningen
GSK Investigational Site, Maastricht
GSK Investigational Site, Nieuwegein
GSK Investigational Site, Nijmegen
GSK Investigational Site, Rotterdam
GSK Investigational Site, Oslo
GSK Investigational Site, Bratislava
GSK Investigational Site, Košice
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Gothenburg
GSK Investigational Site, Linköping
GSK Investigational Site, Lund
GSK Investigational Site, Umeå
GSK Investigational Site, Uppsala
GSK Investigational Site, Cambridge
GSK Investigational Site, Clydebank
GSK Investigational Site, London
GSK Investigational Site, London
GSK Investigational Site, Newcastle upon Tyne
GSK Investigational Site, Sheffield
Lead Sponsor
GlaxoSmithKline
INDUSTRY